Johanna Faris
General Counsel bei SENZIME AB
Vermögen: 754 $ am 30.04.2024
Profil
Johanna Faris is currently the Director of Quality Assurance & Regulatory Affairs at Senzime AB since 2018.
Prior to this, she worked as the Director of Regulatory & Quality Assurance at Biovica International AB from 2016 to 2018.
She also worked as a Manager of Quality Assurance & Regulatory at Fiomi Diagnostics AB.
Ms. Faris completed her undergraduate degree at the University of Uppsala.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SENZIME AB
0,00% | 30.12.2022 | 1 183 ( 0,00% ) | 754 $ | 30.04.2024 |
Aktive Positionen von Johanna Faris
| Unternehmen | Position | Beginn |
|---|---|---|
| SENZIME AB | General Counsel | 01.01.2018 |
Ehemalige bekannte Positionen von Johanna Faris
| Unternehmen | Position | Ende |
|---|---|---|
| BIOVICA INTERNATIONAL AB | General Counsel | 01.08.2018 |
Fiomi Diagnostics AB
 Fiomi Diagnostics AB Medical SpecialtiesHealth Technology Part of MiCo IVD Holdings, LLC, Fiomi Diagnostics AB is a Swedish company that develops, manufactures, and markets diagnostic test kits. The company is based in Uppsala, Sweden. Fiomi Diagnostics was acquired by Trinity Biotech Plc on March 01, 2012 for $13.12 million. | General Counsel | - |
Ausbildung von Johanna Faris
| University of Uppsala | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOVICA INTERNATIONAL AB | Health Technology |
| SENZIME AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Fiomi Diagnostics AB
Fiomi Diagnostics AB Medical SpecialtiesHealth Technology Part of MiCo IVD Holdings, LLC, Fiomi Diagnostics AB is a Swedish company that develops, manufactures, and markets diagnostic test kits. The company is based in Uppsala, Sweden. Fiomi Diagnostics was acquired by Trinity Biotech Plc on March 01, 2012 for $13.12 million. | Health Technology |
